Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listOzagrel

Ozagrel

  • CAS NO.:82571-53-7
  • Empirical Formula: C13H12N2O2
  • Molecular Weight: 228.25
  • MDL number: MFCD00868231
  • EINECS: 919-112-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-19 23:02:33
Ozagrel Structural

What is Ozagrel?

Description

Ozagrel sodium is the first thromboxane (TX2) synthetase inhibitor to be developed as an antithrombotic agent. In patients with angina pectoris, ozagrel sodium reportedly decreases the frequency of anginal attacks and increases exercise tolerance. Other indications for ozagrel sodium currently under study include bronchial asthma and pulmonary thromboembolism.

Originator

Ono (Japan)

The Uses of Ozagrel

Ozagrel is a potent and selective thromboxane A2 inhibitor. Used in the prevention of ischemic stroke injury and maintains a strong effect in vascular contraction and vascular endothelial cell dysfunction.

What are the applications of Application

Ozagrel is a potent and selective thromboxane A2 inhibitor

Definition

ChEBI: Ozagrel is a member of cinnamic acids.

brand name

Xanbon; Cataclot

Properties of Ozagrel

Melting point: 223-224°
Boiling point: 468.0±25.0 °C(Predicted)
Density  1.17±0.1 g/cm3(Predicted)
storage temp.  Sealed in dry,Room Temperature
solubility  DMSO : 50 mg/mL (219.06 mM; Need ultrasonic)
form  Powder
pka 4.43±0.10(Predicted)
color  White to off-white
CAS DataBase Reference 82571-53-7(CAS DataBase Reference)

Safety information for Ozagrel

Computed Descriptors for Ozagrel

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.